Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Neuro-Oncology
|
August 31, 2016
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide
Michael Wahl, Joanna J Phillips, Annette M Molinaro, et al.
Journal of Neuro-Oncology
|
May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment
Ramin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Molecular Cancer Therapeutics
|
October 15, 2014
NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification
Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, et al.
Cancer
|
August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas
Michael Wahl, Susan M Chang, Joanna J Phillips, et al.
Acta Neuropathologica
|
June 27, 2022
Intratumor and informatic heterogeneity influence meningioma molecular classification
Harish N Vasudevan, Abrar Choudhury, Stephanie Hilz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors
Ian Krop, Tim Demuth, Tina Guthrie, et al.
NPJ Digital Medicine
|
August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI
Nate Tran, Tracy L Luks, Yan Li, et al.
Neurosurgery
|
January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma
Alexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
Nicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2021
Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma
Benjamin M Ellingson, John Sampson, Achal Singh Achrol, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Neuro-Oncology
|
August 31, 2016
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide
Michael Wahl, Joanna J Phillips, Annette M Molinaro, et al.
Journal of Neuro-Oncology
|
May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment
Ramin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Molecular Cancer Therapeutics
|
October 15, 2014
NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification
Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, et al.
Cancer
|
August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas
Michael Wahl, Susan M Chang, Joanna J Phillips, et al.
Acta Neuropathologica
|
June 27, 2022
Intratumor and informatic heterogeneity influence meningioma molecular classification
Harish N Vasudevan, Abrar Choudhury, Stephanie Hilz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors
Ian Krop, Tim Demuth, Tina Guthrie, et al.
NPJ Digital Medicine
|
August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI
Nate Tran, Tracy L Luks, Yan Li, et al.
Neurosurgery
|
January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma
Alexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
Nicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2021
Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma
Benjamin M Ellingson, John Sampson, Achal Singh Achrol, et al.
Page
of 10